519.85
+1.05%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Amrutanjan Health Care
Its shares trade on NSE under the ticker AMRUTANJAN.NS. It has been listed since 5 November 2009. In the fiscal year to 31 March 2026, it reported revenue of ₹5.03bn and net income of ₹579.2m. At that date it held total assets of ₹5.09bn and shareholders' equity of ₹3.70bn.
Amrutanjan Health Care Ltd. engages in the manufacture and sale of ayurvedic and allopathic products. The company is headquartered in Chennai, Tamil Nadu. The company went IPO on 2009-11-05. Its segments include OTC Products, Beverages, and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Company’s pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint. Its women's hygiene products include Comfy Snug Fit, Comfy Snug Fit XL and Comfy Snug Fit ULTRA XL. The Company’s beverages include Fruitnik and Fruitnik Electro+.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 5 Nov 2009
- Employees
- 575
- Website
- amrutanjan.com ↗
Leadership
Pay as last reported
- Mr. S. Sambhu PrasadExecutive Chairman of the Board, Managing Director₹16.5m
- Mr. N. SwaminathanChief Financial Officer₹4.5m
- Mr. Mani BhagavatheeswaranChief Marketing Officer
- Mr. M. SrinivasanCompliance Officer, Company Secretary₹3.4m
- Mr. Soumomoy PalGeneral Manager - Information Technology
- Dr. J. RavichandranGeneral Manager - QC/QA/R&D
- Mr. S. JeyakanthChief Operating Officer - Supply Chain and Product Delivery
- Mr. R. NarayananChief Sales Officer
- Ms. Ramaa ArikirevulaNon-Executive Director₹1.1m
- Mr. Govindan RaghavanNon-Executive Director₹1.5m
- Ms. Meenalochani RaghunathanNon-Executive Independent Director₹1.5m
- Mr. Muralidharan SwayambunathanNon-Executive Independent Director₹2.1m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 67
- Environment
- 36
- Social
- 93
- Governance
- 72
- Direct emissions (scope 1)
- 1,083.598 t
- Energy emissions (scope 2)
- 1,116.312 t
- Women in the workforce
- 4.46927%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products in Chennai, India.
- The company's OTC Products segment offers pain management solutions like Pain Balm Extra Power.
- Its Beverages segment produces Fruitnik and Fruitnik Electro+ for oral hydration.
Weaknesses
- Amrutanjan has only 575 employees, which may limit operational scale.
- The company's segments are limited to OTC Products, Beverages, and Others.
- Amrutanjan's pain management center is part of the Others segment, not a standalone business.
Opportunities
- Amrutanjan can expand its Ayurvedic product line in the Indian Health Care sector.
- The Indian market for OTC products shows growth potential in pain and congestion management.
- Fruitnik Electro+ has potential for increased market share in oral hydration drinks.
Threats
- Amrutanjan faces competition from established pharmaceutical companies in India.
- The Indian Health Care sector is highly regulated, affecting product approvals.
- Rising costs of raw materials could impact production efficiency.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.